BioCentury
ARTICLE | Clinical News

Synsorb Cd oligosaccharide: Began phase II

July 27, 1998 7:00 AM UTC

Synsorb Biotech Inc. (TSE:SYB), Calgary, Alberta Product: Synsorb Cd oligosaccharide Indication: Treat recurring diarrhea due to Clostridium difficile Status: SYB will begin U.S. Phase II testing of ...